OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC
Shengnan Li, Han Xia, Zeyu Wang, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1079-1091
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 19

Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 11

Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
Yagang Song, Shuo Tian, Zhanzhan Li, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 59-76
Open Access | Times Cited: 1

Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers
Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2372-2372
Open Access | Times Cited: 7

The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities
Kosuke Mima, Tsuyoshi Hamada, Kentaro Inamura, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 12

Intratumor microbiome: selective colonization in the tumor microenvironment and a vital regulator of tumor biology
Mingjie Jiang, Zhongyuan Yang, Juanjuan Dai, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 11

Activation of NOD1 on tumor-associated macrophages augments CD8 + T cell–mediated antitumor immunity in hepatocellular carcinoma
Feng Zhang, Qiuyu Jiang, Jialiang Cai, et al.
Science Advances (2024) Vol. 10, Iss. 40
Open Access | Times Cited: 4

Intraneoplastic fungal dysbiosis is associated with colorectal cancer progression and host gene mutation
Kai Yuan, Hongzhi Xu, Shengmian Li, et al.
EBioMedicine (2025) Vol. 113, pp. 105608-105608
Closed Access

Exosome-based immunotherapy in hepatocellular carcinoma
Zhihong Liu, Guowei Wang, Zhi Li, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access

Novel Administration Routes, Delivery Vectors, and Application of Vaccines Based on Biotechnologies: A Review
Chung-I Rai, Tsu-Hsiang Kuo, Yuan‐Chuan Chen
Vaccines (2024) Vol. 12, Iss. 9, pp. 1002-1002
Open Access | Times Cited: 3

Prognostic stratification of gastric cancer patients by intratumoral microbiota-mediated tumor immune microenvironment
Wei Gao, Li Fei-Fei, Tina Wu, et al.
Microbial Pathogenesis (2025) Vol. 200, pp. 107296-107296
Closed Access

Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
Yiqin Wang, Yongqiang Li, Yong Lin, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma
Weiming Mou, Zhe Deng, Lingxuan Zhu, et al.
Science Advances (2025) Vol. 11, Iss. 15
Closed Access

Microecological regulation in HCC therapy: Gut microbiome enhances ICI treatment
Xuliang Liu, Shiyao Li, Liming Wang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167230-167230
Open Access | Times Cited: 3

Intratumoral Microbiome: Foe or Friend in Reshaping Tumor Microenvironment Landscape?
Athina A. Kyriazi, Makrina Karaglani, Sofia Agelaki, et al.
(2024)
Open Access | Times Cited: 3

Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer
Xue‐Yuan Bi, Jihan Wang, Cuicui Liu
Biomolecules (2024) Vol. 14, Iss. 8, pp. 917-917
Open Access | Times Cited: 3

Association between ascites Gustave Roussy immune score and the intratumoural microbiome in malignant ascites secondary to hepatocellular carcinoma
ShanTian, Y. Guo, Qingzhi Lan, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112097-112097
Closed Access | Times Cited: 2

Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?
Athina A. Kyriazi, Makrina Karaglani, Sofia Agelaki, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1279-1279
Open Access | Times Cited: 2

Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
Kin Lam Yu, Sj Shen
European Journal of Cancer (2024) Vol. 216, pp. 115195-115195
Open Access | Times Cited: 2

The role of intratumoral microorganisms in the progression and immunotherapeutic efficacy of head and neck cancer
Xuzhe Fang, Weihong Tong, Sheng Wu, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 349-360
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top